BeStock  
Markets › Compare › ACRS vs CGEM

ACRS vs CGEM

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
ACRS · Aclaris Therapeutics$3.44 ▼ 1.71%
CGEM · Cullinan Therapeutics$8.89 ▼ 1.98%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

59106153200248Nov 24, '25May 26, '26Nov 20, '26
  • ACRS +25.1%
  • CGEM -31.2%

Head to head

MetricACRSCGEM
Price$3.44$8.89
Change today▼ 1.71%▼ 1.98%
Market cap$545.63M$577.15M
Return, 3 months-45.5%-59.3%
Return, year to date+14.3%-14.1%
Return, 1 year+37.1%-6.1%
P/E (TTM)––
P/B3.32.1
P/E percentile vs own 5y43rd53rd
Dividend yield––
Revenue growth (YoY, latest qtr)-55.1%–
Net profit growth (YoY)-26.7%+2.4%
Gross margin5.8%–
Operating margin-1,412.4%–
Net margin-1,244.1%–
Return on equity-55.5%-55.5%
Analyst target vs. price+240.4%+282.5%
Analyst buy share100%100%
RSI (14)3926
30-day volatility72.8%102.2%
Max drawdown, 1 year-49.8%-61.3%
Trend readStrong downtrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • CGEM is the largest of the group by market value.
  • ACRS has returned the most over the past year.
  • ACRS has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top